{"id":9951,"date":"2019-01-22T12:07:00","date_gmt":"2019-01-22T11:07:00","guid":{"rendered":"https:\/\/futurehealthbiobank.com\/al\/?p=9951"},"modified":"2019-01-22T12:07:00","modified_gmt":"2019-01-22T11:07:00","slug":"qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij","status":"publish","type":"post","link":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/","title":{"rendered":"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij"},"content":{"rendered":"<h3>Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb kemioterapis\u00eb p\u00ebr trajtimin e skleroz\u00ebs multiple, pjesa d\u00ebrmuese e tyre shfaq\u00ebn p\u00ebrmir\u00ebsime n\u00eb cil\u00ebsin\u00eb e tyre t\u00eb jet\u00ebs.<\/h3>\n<p><!--more--><\/p>\n<p>Studimi i ri shum\u00eb emocionues i cili u publikua k\u00ebt\u00eb muaj, u zhvillua me 110 pacient\u00eb me Skleroz\u00eb Multiple me relapse e pushime t\u00eb simptomave, p\u00ebrgjat\u00eb nj\u00eb periudhe kohore 11 vje\u00e7are. Studimi krahasoi dy grupe: nj\u00ebrit grup ju dha terapia standarde modifikuese e s\u00ebmundjes (DMT), nd\u00ebrsa tjetrit ju dha nj\u00eb transplant qelizash staminale hematopoietike(HSCT) p\u00ebrgjat\u00eb kemioterapis\u00eb.<\/p>\n<p>Pas vler\u00ebsimit t\u00eb ponderimit pas 1 viti dhe pas 5 vjet\u00ebsh, shkenc\u00ebtar\u00ebt zbuluan se 34 pacient\u00eb pjes\u00ebmarr\u00ebs n\u00eb grupin e terapis\u00eb standarde t\u00eb modifikimit t\u00eb s\u00ebmundjes demonstruan nj\u00eb p\u00ebrparim t\u00eb s\u00ebmundjes s\u00eb tyre, krahasuar me vet\u00ebm 3 n\u00eb grupin pjes\u00ebmarr\u00ebs n\u00eb grupin e HSCT. N\u00eb vitin e par\u00eb, ponderimi mesatar p\u00ebr EDSS (Shkalla e statusit t\u00eb paaft\u00ebsis\u00eb s\u00eb zgjeruar) gjithashtu u p\u00ebrmir\u00ebsua n\u00eb grupin e pacient\u00ebve t\u00eb cil\u00ebt mor\u00ebn nj\u00eb transplant me qeliza staminale hematopoietike, nd\u00ebrkoh\u00eb q\u00eb ajo u p\u00ebrkeq\u00ebsua n\u00eb grupin e atyre t\u00eb terapis\u00eb s\u00eb modifikimit t\u00eb s\u00ebmundjes ( DMT).<\/p>\n<p>Nj\u00ebra prej pjes\u00ebmarr\u00ebseve n\u00eb studim, 28 vje\u00e7arja Amanda Loy, mori pjes\u00eb n\u00eb prov\u00ebn klinike dhe asaj ju dha nj\u00eb transplant qelizash staminale hematopoietike:<\/p>\n<blockquote><p>Ting\u00ebllon kaq dramatike, por [trajtimi] ma ktheu prap\u00eb jet\u00ebn time\u2026 Un\u00eb, me t\u00eb v\u00ebrtet\u00eb nuk i prisja gjith\u00eb k\u00ebta p\u00ebrmir\u00ebsime. P\u00ebrfundova duke menduar se, \u2018n\u00ebse un\u00eb t\u00eb pakt\u00ebn nuk b\u00ebhem m\u00eb keq nga kjo pik\u00eb, do t\u00eb jet\u00eb gjith\u00e7ka n\u00eb rregull.\u2019 Pra, gjith\u00eb k\u00ebta p\u00ebrmir\u00ebsime kan\u00eb qen\u00eb plot\u00ebsisht t\u00eb papritura por nj\u00eb surpriz\u00eb e k\u00ebndshme, kjo \u00ebsht\u00eb e sigurt<\/p><\/blockquote>\n<p>P\u00ebrpara transplantit t\u00eb qelizave staminale, Amanda ishte prekur n\u00eb m\u00ebnyr\u00eb serioze prej skleroz\u00ebs multiple. Ajo nuk mundej t\u00eb punonte me koh\u00eb t\u00eb plot\u00eb, kishte probleme me fshik\u00ebz\u00ebn e urin\u00ebs dhe kishte nevoj\u00eb p\u00ebr nj\u00eb bastun p\u00ebr t\u00eb ecur. Sidoqoft\u00eb, vet\u00ebm nj\u00eb vit pas transplantit t\u00eb qelizave staminale prej gjakut t\u00eb saj, ajo vuri re p\u00ebrmir\u00ebsime t\u00eb mahnitshme. Ajo nuk vuante m\u00eb nga simptomat e fshik\u00ebz\u00ebs s\u00eb urin\u00ebs, lodhja, mpirja e gjymtyr\u00ebve t\u00eb saj, mosdurimi i t\u00eb nxehtit apo dhimbja e nervave.<\/p>\n<p>11 vjet m\u00eb von\u00eb, Amanda e diagnostikuar me skleroz\u00eb multiple, kishte p\u00ebsuar aq shum\u00eb p\u00ebrmir\u00ebsime sa ishte kthyer n\u00eb pun\u00eb me koh\u00eb t\u00eb plot\u00eb si m\u00ebsuese n\u00eb SHBA. Ajo, madje, ishte n\u00eb gjendje t\u00eb luante sporte dhe nuk kishte m\u00eb nevoj\u00eb p\u00ebr mjekime p\u00ebr Skleroz\u00ebn Multiple.<\/p>\n<blockquote><p>Ky \u00ebsht\u00eb fakti m\u00eb i fort\u00eb kur krahason transplantin e qelizave staminale me terapin\u00eb standarde p\u00ebr skleroz\u00ebn multiple\u2026 Kjo \u00ebsht\u00eb nj\u00eb prej cop\u00ebzave t\u00eb para t\u00eb prov\u00ebs se &#8211; Po, pacient\u00ebt t\u00eb cil\u00ebt kan\u00eb Skleroz\u00eb Multiple t\u00eb form\u00ebs agresive ja dalin m\u00eb mir\u00eb pas transplantit se krahasuar me terapin\u00eb standarde<\/p><\/blockquote>\n<p><cite>thot\u00eb Harry Atkins, mjek i transplantit t\u00eb Qelizave Staminale n\u00eb Spitalin e Ottawa<\/cite><\/p>\n<p>Nuk ka asnj\u00eb dyshim; rezultatet e k\u00ebsaj prove klinike paraprake jan\u00eb mbres\u00ebl\u00ebn\u00ebse. Megjithat\u00eb, studimi ka kufizimet e veta, pasi ai paraqet p\u00ebrfitime t\u00eb provuara p\u00ebr pacient\u00ebt me Skleroz\u00eb Multiple me relapse e pushime t\u00eb simptomave m\u00eb pak konvencionale. Do t\u00eb nevojiten m\u00eb tep\u00ebr k\u00ebrkime dhe prova klinike p\u00ebr t\u00eb hapur mund\u00ebsit\u00eb m\u00eb t\u00eb gjera p\u00ebr m\u00eb tep\u00ebr transplante t\u00eb qelizave staminale t\u00eb disponueshme p\u00ebr trajtimin e skleroz\u00ebs multiple.<\/p>\n<p>Referenca:<br \/>\n<strong><a href=\"https:\/\/jamanetwork.com\/journals\/jama\/article-abstract\/2720728\">https:\/\/jamanetwork.com\/<\/a><\/strong><br \/>\n<a href=\"https:\/\/www.vox.com\/2019\/1\/15\/18182095\/ms-multiple-sclerosis-stem-cell-transplant\"><strong>https:\/\/www.vox.com\/<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb kemioterapis\u00eb p\u00ebr trajtimin e skleroz\u00ebs multiple, pjesa d\u00ebrmuese e tyre shfaq\u00ebn p\u00ebrmir\u00ebsime n\u00eb cil\u00ebsin\u00eb e tyre t\u00eb jet\u00ebs.<\/p>\n","protected":false},"author":25,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[216],"tags":[],"class_list":["post-9951","post","type-post","status-publish","format-standard","hentry","category-perditesime-klinike"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v26.7) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij | Future Health Biobank<\/title>\n<meta name=\"description\" content=\"Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb kemioterapis\u00eb p\u00ebr trajtimin e skleroz\u00ebs multiple, pjesa d\u00ebrmuese e tyre shfaq\u00ebn p\u00ebrmir\u00ebsime n\u00eb cil\u00ebsin\u00eb e tyre t\u00eb jet\u00ebs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/\" \/>\n<meta property=\"og:locale\" content=\"sq_AL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij\" \/>\n<meta property=\"og:description\" content=\"Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Health Biobank Albania\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-22T11:07:00+00:00\" \/>\n<meta name=\"author\" content=\"jwhybrow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jwhybrow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/\"},\"author\":{\"name\":\"jwhybrow\",\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"headline\":\"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij\",\"datePublished\":\"2019-01-22T11:07:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/\"},\"wordCount\":653,\"commentCount\":0,\"articleSection\":[\"P\u00ebrdit\u00ebsime Klinike\"],\"inLanguage\":\"sq\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/\",\"url\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/\",\"name\":\"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij | Future Health Biobank\",\"isPartOf\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/#website\"},\"datePublished\":\"2019-01-22T11:07:00+00:00\",\"author\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"description\":\"Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb kemioterapis\u00eb p\u00ebr trajtimin e skleroz\u00ebs multiple, pjesa d\u00ebrmuese e tyre shfaq\u00ebn p\u00ebrmir\u00ebsime n\u00eb cil\u00ebsin\u00eb e tyre t\u00eb jet\u00ebs.\",\"breadcrumb\":{\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#breadcrumb\"},\"inLanguage\":\"sq\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Kreu\",\"item\":\"https:\/\/futurehealthbiobank.com\/al\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/#website\",\"url\":\"https:\/\/futurehealthbiobank.com\/al\/\",\"name\":\"Future Health Biobank Albania\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/futurehealthbiobank.com\/al\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sq\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\",\"name\":\"jwhybrow\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sq\",\"@id\":\"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g\",\"caption\":\"jwhybrow\"},\"url\":\"https:\/\/futurehealthbiobank.com\/al\/blog\/author\/jwhybrow\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij | Future Health Biobank","description":"Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb kemioterapis\u00eb p\u00ebr trajtimin e skleroz\u00ebs multiple, pjesa d\u00ebrmuese e tyre shfaq\u00ebn p\u00ebrmir\u00ebsime n\u00eb cil\u00ebsin\u00eb e tyre t\u00eb jet\u00ebs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/","og_locale":"sq_AL","og_type":"article","og_title":"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij","og_description":"Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb","og_url":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/","og_site_name":"Future Health Biobank Albania","article_published_time":"2019-01-22T11:07:00+00:00","author":"jwhybrow","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jwhybrow","Est. reading time":"3 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#article","isPartOf":{"@id":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/"},"author":{"name":"jwhybrow","@id":"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"headline":"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij","datePublished":"2019-01-22T11:07:00+00:00","mainEntityOfPage":{"@id":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/"},"wordCount":653,"commentCount":0,"articleSection":["P\u00ebrdit\u00ebsime Klinike"],"inLanguage":"sq","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/","url":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/","name":"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij | Future Health Biobank","isPartOf":{"@id":"https:\/\/futurehealthbiobank.com\/al\/#website"},"datePublished":"2019-01-22T11:07:00+00:00","author":{"@id":"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"description":"Nj\u00eb prov\u00eb e vog\u00ebl klinike ka arritur t\u00eb demostroj\u00eb se kur pacient\u00ebt me skleroz\u00eb multiple mor\u00ebn nj\u00eb transplant me qeliza staminale p\u00ebrgjat\u00eb marrjes s\u00eb kemioterapis\u00eb p\u00ebr trajtimin e skleroz\u00ebs multiple, pjesa d\u00ebrmuese e tyre shfaq\u00ebn p\u00ebrmir\u00ebsime n\u00eb cil\u00ebsin\u00eb e tyre t\u00eb jet\u00ebs.","breadcrumb":{"@id":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#breadcrumb"},"inLanguage":"sq","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/futurehealthbiobank.com\/al\/blog\/qelizat-staminale-ja-dalin-te-stopojne-sklerozen-multiple-ne-studimin-pionier-ne-llojin-e-tij\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Kreu","item":"https:\/\/futurehealthbiobank.com\/al\/"},{"@type":"ListItem","position":2,"name":"Qelizat Staminale ja dalin t\u00eb stopojn\u00eb Skleroz\u00ebn Multiple n\u00eb studimin pionier n\u00eb llojin e tij"}]},{"@type":"WebSite","@id":"https:\/\/futurehealthbiobank.com\/al\/#website","url":"https:\/\/futurehealthbiobank.com\/al\/","name":"Future Health Biobank Albania","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurehealthbiobank.com\/al\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sq"},{"@type":"Person","@id":"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719","name":"jwhybrow","image":{"@type":"ImageObject","inLanguage":"sq","@id":"https:\/\/futurehealthbiobank.com\/al\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c9af53d69103cbfe6f956d3ca06fe15f77fe26760b48a18012d4a05637201dad?s=96&d=mm&r=g","caption":"jwhybrow"},"url":"https:\/\/futurehealthbiobank.com\/al\/blog\/author\/jwhybrow\/"}]}},"_links":{"self":[{"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/posts\/9951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/comments?post=9951"}],"version-history":[{"count":0,"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/posts\/9951\/revisions"}],"wp:attachment":[{"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/media?parent=9951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/categories?post=9951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurehealthbiobank.com\/al\/wp-json\/wp\/v2\/tags?post=9951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}